GSE134025

Ulcerative colitis gene expressions file

Whole-study status Not suitable

Dataset does not meet the current suitability threshold.

Whole-study downloads — these do not apply your sample requirements.

Selected cohort requirements

Samples meeting selected requirements: 0 cases / 0 controls

View matching samples

3 case / 3 control samples elsewhere in the study have incomplete or conflicting evidence; they are not included above

Patient pairs verified in indexed sample metadata: 0

A case/control comparison meeting these requirements is not confirmed.

Counts describe samples, not independent patients. Pair verification uses explicit subject identifiers in indexed sample metadata. Zero verified pairs does not establish that the study is unpaired; reported matched-normal design alone is insufficient.

Summary

Ulcerative colitis related gene expressions analysis in colonic biopsy samples from control and ulcerative colitis patients

Overall design

Three paired colonic mucosal samples from colitis patients and control individuals were collected. Total RNA of each one was extracted and reverse transcribed into cDNA. The cDNA then processed for gene expression microanalysis.

Source Evidence

4 sources
Source Contribution Status
GEO

Original dataset metadata, sample metadata, source links, and GEO data availability flags.

Sample records
6 GSM samples
Primary source
recount3

Planned trusted source for processed count availability.

No match found
Expression Atlas

Planned source for curated expression experiment links.

No match found
PubMed

Primary GEO citations and related PubMed articles that mention this dataset.

4 linked publications 3 DOIs

Primary publication

  1. Ferroptosis involves in intestinal epithelial cell death in ulcerative colitis. Cell death & disease, 2020

Related publications

  1. Gancao Xiexin decoction attenuated experimental colitis through suppressing ACSL4-mediated ferroptosis. Journal of ethnopharmacology, 2025
  2. Identification of Pharmacological Autophagy Regulators of Active Ulcerative Colitis. Frontiers in pharmacology, 2021
  3. [Bioinformatic analysis of molecular mechanism of IL-17 in regulating ulcerative colitis]. Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology, 2023
Available

Metadata Quality Components

Analysis Readiness

Ready after review
97% DE readiness

Contrast completeness

25/25 pts

Both case and control groups are present in the proposed grouping.

Minimum group size

20/20 pts

Each contrast group has at least 2 samples.

Processed data availability

20/20 pts

Processed data is marked available in the GEO index.

Sample decision clarity

15/15 pts

All samples are assigned to a case or control group.

Blocking warnings

7/10 pts

Warnings are present, but none are critical blockers.

Metadata normalization

10/10 pts

Metadata quality is high enough to support downstream handoff.

Blockers

No readiness blockers detected.

Next Steps

  • Verify the proposed sample assignments and case-versus-control comparison against the GEO metadata before using them in DESeq2 or another differential-expression tool.
  • Confirm processed count files and sample identifiers match the exported metadata.

Analysis Preparation Checklist

5/6 ready

Group labels reviewed

Needs review

Siftome proposed case and control labels, but no reviewer confirmation is stored yet.

Open the sample grouping CSV and confirm group labels before analysis.

Minimum sample count met

Ready

Both groups meet the minimum of 2 samples.

Confirm whether the cohort is large enough for the intended statistical analysis.

Processed counts available

Ready

Processed data availability is marked true in the GEO index.

Verify that downloaded processed files contain usable count or expression identifiers.

Ambiguous samples handled

Ready

No review-needed or unassigned samples are present in the proposed grouping.

Review the grouping table for biologically meaningful differences that the automated checks may not detect.

Exclusion decisions recorded

Ready

No hard-excluded samples were detected by the current rules.

Record any manual exclusions in the downstream analysis notes.

Source traceability preserved

Ready

The dataset and sample accessions can be traced back to GEO.

Keep GEO accessions with exported metadata.

Bioinformatician Review

Bioinformatician review required

Ask a bioinformatician to review grouping, count availability, exclusions, and design before DE.

Assay context may require expert handling before DESeq2-style analysis.

Why This Is Ranked Here

Tumor vs normal
Not suitable Dataset does not meet the current suitability threshold.

Applied Review Decisions

No active review decisions affect this ranking.

Derived Classifications

  • Assay differs from search intent Microarray Search intent expects bulk RNA-seq. Assay came from Normalization rules.
  • Disease context Ulcerative colitis Disease context came from Normalization rules.
  • Likely case group Ulcerative colitis 3 samples
  • Likely control group Healthy control 3 samples

Intent Interpretation

  • Downgrade or exclusion reason Downgraded assay: microarray cohorts are separated from the RNA-seq intent. Derived from current-intent ranking reasons.

Ranking Facts

Supporting evidence

  • Comparison: Disease/model vs control. Specimen: Tissue. Comparison suitability: 0%.
  • Interpreted disease metadata: Ulcerative colitis.
  • Processed data is available for downstream review.
  • External evidence: PubMed links 4 publications; 3 DOIs available: PMID 32015337, PMID 34925026, PMID 36631011, PMID 39993549.
  • Publication context: Ferroptosis involves in intestinal epithelial cell death in ulcerative colitis.. Cell death & disease, 2020. PMID 32015337. DOI 10.1038/s41419-020-2299-1.
  • Publication context: Identification of Pharmacological Autophagy Regulators of Active Ulcerative Colitis.. Frontiers in pharmacology, 2021. PMID 34925026. DOI 10.3389/fphar.2021.769718.
  • Publication context: [Bioinformatic analysis of molecular mechanism of IL-17 in regulating ulcerative colitis].. Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology, 2023. PMID 36631011.
  • Publication context: 1 additional linked PubMed publications are available.

Cautions

  • Downgraded assay: microarray cohorts are separated from the RNA-seq intent.
  • Disease/control design without a tumor/normal comparison is outside tumor/normal triage.
  • Overall score capped because comparison suitability is weak for the selected search intent.
  • Overall score capped because fewer than ten samples limit cohort confidence.
  • Comparison suitability score is below the Phase 1 recommended threshold.

Dataset Warnings

Normalized Fields

34 fields

Sample Group Preview

6 rows shown
Show Hide
Study totals: Case 3 | Control 3 | Unassigned 0 | Excluded 0 | Ambiguous 0 6 rows shown
Group Role Accession Title Source / characteristics Reason
Ulcerative colitis Case GSM3933487 UC patient 1 Colonic mucosal sample Tissue: Colonic mucosa; Diagnosis: Ulcerative colitis Case marker detected.
Ulcerative colitis Case GSM3933488 UC patient 2 Colonic mucosal sample Tissue: Colonic mucosa; Diagnosis: Ulcerative colitis Case marker detected.
Ulcerative colitis Case GSM3933489 UC patient 3 Colonic mucosal sample Tissue: Colonic mucosa; Diagnosis: Ulcerative colitis Case marker detected.
Healthy control Control GSM3933490 Normal 1 Colonic mucosal sample Tissue: Colonic mucosa; Diagnosis: Healthy control Sample-local control marker detected.
Healthy control Control GSM3933491 Normal 2 Colonic mucosal sample Tissue: Colonic mucosa; Diagnosis: Healthy control Sample-local control marker detected.
Healthy control Control GSM3933492 Normal 3 Colonic mucosal sample Tissue: Colonic mucosa; Diagnosis: Healthy control Sample-local control marker detected.

Use as Discovery Cohort

External Validation Finder

Carry Siftome's disease, organism, specimen, assay, data type, and accession into a validation project. Uncertain fields remain Unknown.